本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 河南清水源科技股份有限公司（以下简称"公司"）第六届董事会第十一次 会议于 2025 年 4 月 28 日上午 9:00 在公司研发中心二楼会议室以现场表决方式 召开。会议通知及会议材料已于 2025 年 4 月 11 日以邮件、电话方式通知了各位 董事及相关与会人员。会议应出席董事 9 名，实际出席董事 9 名。公司监事及高 级管理人员列席了本次会议。本次会议由公司董事长王志清先生召集并主持，会 议的召集、召开、表决符合《中华人民共和国公司法》和《河南清水源科技股份 有限公司章程》的规定。 二、董事会会议审议情况 本次会议经与会董事审议并书面表决，通过如下决议： （一）审议通过《关于公司<2024 年年度报告>全文及其摘要的议案》，本 议案尚需提交股东会审议批准。 证券代码：300437 证券简称：清水源 公告编号：2025-039 河南清水源科技股份有限公司 关于第六届董事会第十一次会议决议的公告 经审议，公司董事会认为公司编制《2024 年年度报告》及其摘要的程序符 合法律、行政法规 ...

河南清水源科技股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召 开第六届董事会第十一次会议及第六届监事会第九次会议，分别审议通过了《关 于公司 2024 年度利润分配预案的议案》。该事项已经公司独立董事专门会议审 议通过，尚需提交公司 2024 年度股东会审议。 二、2024 年利润分配预案的基本情况 根据致同会计师事务所（特殊普通合伙）出具的 2024 年度审计报告，公司 2024 年度合并报表实现归属于上市公司股东的净利润为-58,610,133.27 元，母 公司 2024 年度实现净利润为-41,986,956.78 元。截至 2024 年 12 月 31 日，公 司合并报表累计未分配利润为 12,272,485.78 元，母公司报表累计未分配利润为 317,713,508.43 元。鉴于公司 2024 年度发生亏损，未能实现盈利，在综合考 虑公司实际经营发展情况和资金需求，以及公司长期发展规划的情况下，公司 2024 年度利润分配预案为：2024 年度不派发现金红利，不送红股，不以资本公 积转增股本。 三、2024 年利润分配预案说明 证券代码：300437 证券简称：清水源 公 ...

河南清水源科技股份有限公司 营业收入扣除情况表 专项核查报告 致同会计师事务所（特殊普通合伙） 目 录 专项核查报告 公司 2024 年度营业收入扣除情况表及说明 1-2 致同会计师事务所（特殊普通合伙） 中国北京 朝阳区建国门外大街 22 号 赛特广场 5 层 邮编 100004 电话 +86 10 8566 5588 传真 +86 10 8566 5120 www.grantthornton.cn 河南清水源科技股份有限公司 营业收入扣除情况表专项核查报告 致同专字（2025）第 410A011913 号 本核查报告仅供清水源公司披露营业收入扣除事项及扣除后的营业收入 金额使用，不得用作任何其他用途。 中国注册会计师 河南清水源科技股份有限公司全体股东： 我们接受委托，在审计了河南清水源科技股份有限公司（以下简称"清 水源公司"）2024 年 12 月 31 日的合并及公司资产负债表，2024 年度的合并及 公司利润表、合并及公司现金流量表、合并及公司股东权益变动表以及财务 报表附注的基础上，对后附的《河南清水源科技股份有限公司 2024 年度营业 收入扣除情况表及说明》（以下简称"营业收入扣除情况表"） ...

致同会计师事务所（特殊普通合伙） 目 录 关于河南清水源科技股份有限公司 非经营性资金占用及其他关联 资金往来的专项说明 关于河南清水源科技股份有限公司非经营性资金占用及其他关联 资金往来的专项说明 河南清水源科技股份有限公司 2024年度非经营性资金占用及其他 关联资金往来情况汇总表 致同会计师事务所（特殊普通合伙） 中国北京 朝阳区建国门外大街 22 号 赛特广场 5 层 邮编 100004 电话 +86 10 8566 5588 传真 +86 10 8566 5120 www.grantthornton.cn 关于河南清水源科技股份有限公司 非经营性资金占用及其他关联资金往来的专项说明 致同专字（2025）第 410A011915 号 河南清水源科技股份有限公司全体股东： 我们接受河南清水源科技股份有限公司（以下简称"清水源公司"）委 托，根据中国注册会计师执业准则审计了清水源公司 2024年 12月 31日的合并 及公司资产负债表，2024 年度合并及公司利润表、合并及公司现金流量表、 合并及公司股东权益变动表和财务报表附注，并出具了致同审字（2025）第 410A020979 号无保留意见审计报告。 ...

关于河南清水源科技股份有限公司 2024 年度上期非标事项在本期消除 的专项说明 致同会计师事务所（特殊普通合伙） 致同会计师事务所（特殊普通合伙） 中国北京 朝阳区建国门外大街 22 号 赛特广场 5 层 邮编 100004 电话 +86 10 8566 5588 传真 +86 10 8566 5120 www.grantthornton.cn 关于河南清水源科技股份有限公司 2024 年度上期非标事项在本期消除的专项说明 致同专字（2025）第 410A011916 号 河南清水源科技股份有限公司全体股东： 我们接受委托，审计了河南清水源科技股份有限公司（以下简称"清水 源公司"）2024 年度财务报表，包括 2024 年 12 月 31 日的合并及公司资产负 债表，2024 年度的合并及公司利润表、合并及公司现金流量表、合并及公司 股东权益变动表和相关财务报表附注，并于 2025 年 4 月 28 日出具了标准无 保留意见的审计报告（致同审字（2025）第 410A020979 号）。我们的审计是 依据中国注册会计师执业准则进行的。 根据中国证券监督管理委员会《监管规则适用指引——审计类第 1 号》 的 ...

河南清水源科技股份有限公司 二〇二四年度 内部控制审计报告 致同会计师事务所（特殊普通合伙） 致同会计师事务所（特殊普通合伙） 中国北京 朝阳区建国门外大街 22 号 赛特广场 5 层 邮编 100004 电话 +86 10 8566 5588 传真 +86 10 8566 5120 www.grantthornton.cn 内部控制审计报告 致同审字（2025）第 410A020980 号 河南清水源科技股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求， 我们审计了河南清水源科技股份有限公司（以下简称"清水源公司"）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》《企业内部控制应用指引》和《企业内 部控制评价指引》的规定，建立健全和有效实施内部控制，并评价其有效性 是清水源公司董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性 发表审计意见，并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性，存在不能防止 ...

河南清水源科技股份有限公司 二〇二四年度 审计报告 致同会计师事务所（特殊普通合伙） 致同会计师事务所（特殊普通合伙） 中国北京朝阳区建国门外大街 22 号 赛特广场 5 层邮编 100004 电话 +86 10 8566 5588 传真 +86 10 8566 5120 www.grantthornton.cn 审计报告 致同审字（2025）第 410A020979 号 河南清水源科技股份有限公司全体股东： 一、审计意见 我们审计了河南清水源科技股份有限公司（以下简称"清水源公司"） 财务报表，包括 2024 年 12月 31 日的合并及公司资产负债表，2024 年度的合并 及公司利润表、合并及公司现金流量表、合并及公司股东权益变动表以及相 关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编 制，公允反映了清水源公司 2024年 12月 31日的合并及公司财务状况以及 2024 年度的合并及公司经营成果和现金流量。 二、形成审计意见的基础 目 录 | 审计报告 | 1-5 | | --- | --- | | 合并及公司资产负债表 | 1-2 | | 合并及公司利润表 | 3 | ...

Financial Performance - In 2024, the company achieved operating revenue of 1.092 billion RMB, a decrease of 3.77% compared to the same period last year[4]. - The net profit attributable to shareholders was -59 million RMB, down 4.99% year-on-year, marking a loss for the year[4]. - The decline in revenue and gross profit was primarily due to a decrease in product sales prices influenced by market conditions, despite stable sales volume of water treatment agents[4]. - The company's operating revenue for 2024 was ¥1,091,796,593.72, a decrease of 3.77% compared to ¥1,134,545,865.66 in 2023[19]. - The net profit attributable to shareholders for 2024 was -¥58,610,133.27, reflecting a decline of 4.99% from -¥55,826,716.33 in 2023[19]. - The net cash flow from operating activities increased by 69.66% to ¥114,726,708.44 in 2024, compared to ¥67,623,479.43 in 2023[19]. - The total assets at the end of 2024 were ¥2,561,540,628.45, down 7.12% from ¥2,757,868,330.39 at the end of 2023[19]. - The company reported a basic earnings per share of -¥0.2277 for 2024, a decrease of 5.66% from -¥0.2155 in 2023[19]. - The company experienced a significant improvement in net profit excluding non-recurring items, which was -¥19,154,573.53 in 2024, a 34.82% improvement from -¥29,385,421.25 in 2023[19]. Business Operations - The company operates primarily in the water treatment agent and derivative products sector, focusing on production, sales, and terminal services[29]. - The company has an annual production capacity of 270,000 tons of water treatment agents, indicating a strong position in the industry[34]. - The company has evolved from a single water treatment agent manufacturer to a diversified group covering water treatment agents, industrial water treatment engineering, and comprehensive water environment governance[41]. - The company operates several subsidiaries, including Qingyuan Water Treatment, which is a leading manufacturer of water treatment chemicals with a large production capacity and a diverse product range[41]. - The company’s water treatment services include industrial water treatment system design, equipment integration, and municipal wastewater engineering, primarily acquired through public bidding[46]. Market and Industry Trends - The demand for water treatment agents is expected to continue increasing due to the growing water resource scarcity and ongoing ecological civilization construction[33]. - The water treatment agent market in China is characterized by low concentration and intense competition, with many small and medium-sized enterprises present[32]. - The industry is expected to see stricter environmental regulations, which will drive the demand for high-quality water treatment agents[33]. - The company faces challenges due to severe water resource shortages and significant water pollution issues in China, impacting industrial development[30]. Research and Development - The company is committed to enhancing its R&D capabilities by building a team of experts and focusing on the commercialization of innovative technologies[36]. - The company aims to enhance its core competitiveness by focusing on the development of green and environmentally friendly water treatment products[35]. - The company filed for 14 invention patents and 16 utility model patents during the reporting period, with a total of 25 invention patents and 123 utility model patents currently held[62]. - The company is advancing several R&D projects, including environmentally friendly water treatment agents and improvements in production processes, aimed at sustainable development[76][78]. Risk Management - The company is actively monitoring potential risks and has outlined corresponding countermeasures in its future development outlook[6]. - Future plans and strategic developments are subject to investment risks, and the company advises investors to be cautious[6]. - The company faces risks from fluctuations in raw material and product prices, which can impact gross margins and profitability due to significant price volatility during the reporting period[108]. - The company is implementing measures to mitigate risks associated with new project construction delays, including enhancing communication with regulatory bodies and strengthening technical collaborations[109]. Corporate Governance - The governance structure is compliant with relevant laws and regulations, ensuring effective checks and balances among the board, shareholders, and management[119]. - The company is committed to transparency and equal treatment of all shareholders, facilitating participation in significant decisions through accessible shareholder meetings[120]. - The company has established a dedicated investor relations management system to ensure compliance with information disclosure regulations, enhancing transparency for all shareholders[127]. - The company has a clear governance structure that complies with legal and regulatory requirements, with no significant discrepancies noted[127]. Employee Management - The total number of employees at the end of the reporting period was 862, with 807 in major subsidiaries[163]. - The professional composition includes 474 production personnel, 69 sales personnel, 144 technical personnel, 30 financial personnel, 111 administrative personnel, and 34 management personnel[163]. - The company has established a multi-level, long-term incentive system to attract and retain talent, aligning employee interests with company goals[180]. - The company has implemented a rigorous evaluation mechanism to objectively assess employee qualifications and performance, promoting a focus on personal development and long-term company growth[164]. Future Outlook - The company aims to enhance its water treatment agent R&D and production capabilities, focusing on green and environmentally friendly products[102]. - By 2025, the company plans to optimize its water treatment agent production capacity and expand its market presence[103]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[148]. - The company has allocated 100 million yuan for research and development in the upcoming fiscal year[148].

Financial Performance - The company's revenue for Q1 2025 was ¥204,511,043.25, a decrease of 28.45% compared to ¥285,843,137.73 in the same period last year[5] - The net profit attributable to shareholders was -¥5,173,961.26, representing a decline of 252.05% from a profit of ¥3,402,793.17 in the previous year[5] - Basic and diluted earnings per share were both -¥0.0202, a decrease of 254.20% from ¥0.0131 in the previous year[5] - The net profit for the current period is -4,865,354.21, compared to a net profit of 4,103,867.20 in the previous period, indicating a significant decline[20] - The total profit for the current period is -3,530,278.60, down from 7,086,419.32 in the previous period[20] - The total comprehensive income for the current period is -4,868,539.74, compared to 4,107,726.71 in the previous period[20] Cash Flow - The net cash flow from operating activities was -¥14,333,623.97, a slight increase in loss of 3.21% compared to -¥13,887,914.45 in the same period last year[5] - Cash flow from operating activities shows a net outflow of -14,333,623.97, compared to -13,887,914.45 in the previous period[22] - Cash flow from investing activities results in a net outflow of -467,274.35, compared to -70,947.93 in the previous period[23] - Cash flow from financing activities shows a net outflow of -22,511,330.80, compared to -43,207,067.22 in the previous period[23] - The company received cash from operating activities totaling 162,248,809.26, down from 200,326,017.00 in the previous period[22] - The company reported a decrease in sales cash receipts from 188,468,150.00 in the previous period to 159,318,704.97 in the current period[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,424,625,491.04, down 5.35% from ¥2,561,540,628.45 at the end of the previous year[5] - The total assets as of March 31, 2025, are CNY 2,424,625,491.04, down from CNY 2,561,540,628.45 at the beginning of the period, indicating a decrease of approximately 5.3%[16] - The total liabilities decreased from CNY 1,122,212,166.91 to CNY 987,746,114.54, reflecting a reduction of about 11.9%[16] - The company's cash and cash equivalents decreased to CNY 355,163,264.90 from CNY 401,610,338.55, a decline of approximately 11.5%[15] - The company’s total equity as of March 31, 2025, is CNY 1,436,879,376.50, a slight decrease from CNY 1,439,328,461.54 at the beginning of the period[17] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 25,985, with the largest shareholder holding 37.74% of the shares[9] - The company has completed the repurchase and cancellation of 4,640,186 shares at a total price of CNY 1.00, as approved in the board meetings held on January 23 and February 13, 2025[12] Accounting and Auditing - The company did not undergo any audit for the quarterly report, indicating that the financial data has not been externally verified[4] - The company has corrected accounting errors for the years 2016-2023, which may impact the financial statements and reported figures for those years[13] Operational Performance - The decline in net profit was primarily due to a decrease in the gross margin of the company's main products, water treatment agents and derivatives[8] - The total operating revenue for the current period is CNY 204,511,043.25, a decrease of approximately 28.5% compared to CNY 285,843,137.73 in the previous period[19] - The total operating costs for the current period amount to CNY 205,335,994.45, down from CNY 279,314,131.71, reflecting a reduction of about 26.5%[19] - The net profit for the current period is not explicitly stated, but the significant decrease in both revenue and costs indicates potential challenges in profitability[19]

证券代码：300437 证券简称：清水源 公告编号：2025-037 河南清水源科技股份有限公司 关于延期披露 2024 年年度报告及 2025 年第一季度报告的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 河南清水源科技股份有限公司（以下简称"公司"）原定于 2025 年 4 月 29 日披露公司《2024 年年度报告》及《2025 年第一季度报告》，根据目前定期报 告编制工作进展情况，本着审慎原则及对广大投资者负责的态度，为保证信息披 露的准确性和完整性，经公司申请，将公司《2024 年年度报告》及《2025 年第 一季度报告》披露时间调整至 2025 年 4 月 30 日。 公司指定的信息披露媒体为《证券时报》《上海证券报》和巨潮资讯网 （www.cninfo.com.cn），有关信息均以公司在上述指定媒体披露的公告为准， 敬请广大投资者理性投资，注意投资风险。 特此公告。 河南清水源科技股份有限公司董事会 2025 年 4 月 28 日 公司董事会对此次调整定期报告披露时间给投资者带来的不便致以诚挚的 歉意，敬请广大投资者谅解。 ...